CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Business Officer sold 75,000 shares at $37.95 ($2,846,310)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $37.78 ($472,252)
- 4 Open-market sale CFO sold 20,000 shares at an average $38.92 ($778,399)
- 4 Open-market sale CFO sold 30,000 shares at $50.00 ($1,500,000)
- 4 Open-market sale EVP, Research & CSO sold 14,920 shares at an average $44.64 ($666,058)
- 4 Open-market sale CFO sold 10,000 shares at $40.00 ($400,000)
- 4 Open-market sale EVP, Research & CSO sold 3,510 shares at an average $38.00 ($133,384)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $37.27 ($465,815)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $36.28 ($138,030)
- 4 Open-market sale Chief Medical Officer sold 12,500 shares at an average $35.07 ($438,387)
- 4 Open-market sale Chief Business Officer sold 75,000 shares at $35.22 ($2,641,410)
- 4 Open-market sale CFO sold 10,000 shares at an average $35.10 ($351,038)
- 4 Open-market sale EVP, Research & CSO sold 3,805 shares at $34.08 ($129,674)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 22 of 25 · 491 filings